XTL Biopharmaceuticals Ltd. announced it accepted an invitation to join Lupus Foundation of America (LFA)’s Corporate Advisory Council (CAC). XTL is…
Articles by Ines Martins, PhD
Aurinia Pharmaceuticals  has completed the initial analysis of voclosporin in its AURION trial, an open label, single arm, exploratory trial…
Research conducted on medical records from over a quarter million adult patients found that African-Americans with connective tissue diseases…
Lupus during pregnancy increases the likelihood of health complications for women and their babies, according to a study, “What to…
Aurinia Pharmaceuticals, Inc., has announced its AURA-LV clinical study has completed enrollment and will be treating a total of 265 lupus…
Neovacs and Stellar Biotechnologies have collaborated to form a new biotech company called Neostell SAS. Neovacs will own 70 percent of…
Systemic lupus erythematosus (SLE) patients may be at a higher risk of seizures if they have a history of psychosis, neuropathy, proteinuria,…
XTL Biopharmaceuticals has announced it has submitted the full protocol for its advanced stage clinical trial of hCDR1 in the treatment…
Neovacs announced it has concluded a four-year, €5 million ($5.5 million) non-dilutive funding agreement to finalize clinical development and start the production process for its therapeutic…
Dutch biopharmaceutical company argenx recently announced the completion of the dose-escalation stage of a Phase 1 clinical trial exploring its drug candidate…